Results 151 to 160 of about 355,709 (346)

Type and location of P53 suppressor gene mutations in 332 Polish non-small cell lung cancer (NSCLC) patients [PDF]

, 2000
Ewa Jassem, Joanna Jaworska, Maciej Żylicz, Wiesława Niklińska, Jacek Nikliński, Piotr Barski, R. Rosell, G Kobierska, Witold Rzyman, L Chyczewski, J Jassem   +10 more
openalex   +1 more source

RPSLearner: A Novel Approach Based on Random Projection and Deep Stacking Learning for Categorizing Non‐Small Cell Lung Cancer

Advanced Intelligent Systems, EarlyView.
Identifying non‐small cell lung cancer (NSCLC) subtypes is essential for precision cancer treatment. Conventional methods are laborious, or time‐consuming. To address these concerns, RPSLearner is proposed, which combines random projection and stacking ensemble learning for accurate NSCLC subtyping. RPSLearner outperforms state‐of‐the‐art approaches in
Xinchao Wu, Jieqiong Wang, Shibiao Wan
wiley   +1 more source

183 Twice-weekly gemcitabine and concurrent thoracic radiotherapy - a phase I/II study in patients with advanced non-small cell lung cancer (NSCLC)

, 1999
A. William Blackstock, L. D. Case, Frederick Richards, David M. White, Marvin Petty, Charles W. Scarantino, Andrew T. Turrisi   +6 more
openalex   +1 more source

Do elderly patients (pts) with locally advanced non-small cell lung cancer (NSCLC) benefit from combined modality therapy? a secondary analysis of RTOG 94-10 [PDF]

, 2001
Corey J. Langer, Chun-Yao Hsu, Walter J. Curran, Ritsuko Komaki, J.S. Lee, Roger W. Byhardt, William T. Sause   +6 more
openalex   +1 more source

Approaches to Enhance Photodynamic Therapy of Lung Cancer: Potential Application of Nanoparticles

Advanced NanoBiomed Research, EarlyView.
Bioactive ligand‐targeted nanocarriers can accommodate functionalization with numerous targeting ligands for effective delivery of photosensitizers (PSs) within targeted photodynamic therapy. Various targeting moieties including peptides, antibodies, carbohydrates, aptamers, proteins, and PS anticancer molecules can be attached to nanomaterials.
Nokuphila Winifred Nompumelelo Simelane, Heidi Abrahamse   +1 more
wiley   +1 more source

114 Preoperative accelerated radiotherapy (RT) and concurrent chemotherapy (CT) for stage IIIA (N2) non-small cell lung cancer (NSCLC): Improved survival by enhanced local tumor control

, 1995
N.C. Choi, Douglas J. Mathisen, Robert W. Carey, John Wain, Alan D. Hilgenberg, W. Daly, Ashby C. Moncure, C. Wright, Thomas J. Lynch, Hermes C. Grillo   +9 more
openalex   +1 more source

Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer (NSCLC) [PDF]

, 2001
Fumihiro Tanaka, Kazuhiro Yanagihara, Yosuke Otake, Tomoko Yamada, Tsuyoshi Shoji, Ryo Miyahara, Kenji Inui, Hiromi Wada   +7 more
openalex   +1 more source

The Cost of NSCLC in France [PDF]

Value in Health, 2013
Alistair McGuire, M. Martin, C. Lenz, R. Marty   +3 more
openaire   +2 more sources

Copper‐Containing Mesoporous Bioactive Glass Nanoparticles: A Novel Radiosensitizer for Nonsmall Cell Lung Cancer

Advanced NanoBiomed Research, EarlyView.
Cu‐MBGNs enhance the efficacy of radiotherapy for nonsmall cell lung cancer (NSCLC), exhibiting selective cytotoxicity toward cancer cells while maintaining minimal toxicity to normal cells. Cu‐MBGNs amplify radiation‐induced ROS through silica‐mediated generation and Cu2+/Cu+ redox catalysis.
Jingyi He, Sihong Ouyang, Xiaofeng Chen, Conghua Xie   +3 more
wiley   +1 more source

120 Response, toxicity, failure patterns and survival in five radiation therapy oncology group (RTOG) trials of sequential and/or concurrent chemotherapy (CT) and radiation therapy (RT) for locally advanced non-small cell carcinoma of the lung (NSCLC)

, 1997
R. Byhardt, C. Scott, W. Sause, B. Emami, R. Komaki, B. Fisher, J. Lee, C. Lawton   +7 more
openalex   +1 more source